Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Avrita Campinha-Bacote"'
Autor:
Jonathan W. Friedberg, Carrie A. Thompson, Marek Trněný, Franck Morschhauser, Gilles Salles, Patrick M. Reagan, Mark Hertzberg, Piotr Smolewski, Huilai Zhang, Catherine Thieblemont, Bei Hu, Gustavo Fonseca, Won-Seog Kim, Maurizio Martelli, Amitkumar Mehta, Avrita Campinha-Bacote, Mark Yan, Jamie Hirata, Matthew Sugidono, Calvin Lee, Jeff P. Sharman
Publikováno v:
Blood. 140:6623-6626
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87d8a8053652170e35189e076d547a98
https://doi.org/10.1182/blood-2022-157761
https://doi.org/10.1182/blood-2022-157761
Autor:
Amy D. Shapiro, Sylvia von Mackensen, Michael U. Callaghan, Ido Paz-Priel, Midori Shima, Steven W. Pipe, Víctor Jiménez-Yuste, Claude Negrier, Gallia G. Levy, Markus Niggli, Johnny Mahlangu, Sammy Chebon, Avrita Campinha-Bacote, Mark W. Skinner, Michaela Lehle, Johannes Oldenburg
Publikováno v:
Haemophilia
Introduction Severe haemophilia A (HA) has a major impact on health‐related quality of life (HRQoL). Aim Assess the impact of emicizumab on HRQoL in persons with severe HA (PwHA) without factor VIII (FVIII) inhibitors in the phase 3 HAVEN 3 and 4 s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b187485c94a41adafcf8090c856810f
https://doi.org/10.1111/hae.14363
https://doi.org/10.1111/hae.14363
Autor:
Scott David Ramsey, Veena Shankaran, Aasthaa Bansal, Kaiyue Yu, Morgan Glascock, Karma L. Kreizenbeck, Kate Watabayashi, Richa Wilson, Annika Ittes, Canan Bilgin Keciciler, Avrita Campinha-Bacote, Wei Yu, Elaine Yu
Publikováno v:
Journal of Clinical Oncology. 40:444-444
444 Background: Almost half of the nearly 370,000 pts with cancer who receive chemotherapy in the United States each year experience Emergency Department (ED) visits and unplanned inpatient (IP) stays during treatment, largely due to poorly controlle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65b779184e49df3f04b0249cf3ef7d2f
https://doi.org/10.1200/jco.2022.40.28_suppl.444
https://doi.org/10.1200/jco.2022.40.28_suppl.444
Autor:
Scott David Ramsey, Veena Shankaran, Aasthaa Bansal, Kaiyue Yu, Morgan Glascock, Karma L. Kreizenbeck, Kate Watabayashi, Richa Wilson, Annika Ittes, Canan Bilgin Keciciler, Avrita Campinha-Bacote, Wei Yu, Elaine Yu
Publikováno v:
Journal of Clinical Oncology. 40:443-443
443 Background: Up to half of pts with cancer receiving systemic therapy have unplanned emergency department or hospital admission during treatment. ML41539 is a prospective observational study of an app to collect electronic patient-reported outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::585f3a279e833c3590a2578ae69c47e1
https://doi.org/10.1200/jco.2022.40.28_suppl.443
https://doi.org/10.1200/jco.2022.40.28_suppl.443
Autor:
Niamh M O'Connell, Johnny Mahlangu, Avrita Campinha-Bacote, Michael U. Callaghan, Christine L. Kempton, Markus Niggli, Aric Parnes, Peter Trask, Ido Paz-Priel
Publikováno v:
Haemophilia
Introduction Emicizumab is a subcutaneously (SC) administered prophylactic agent for persons with haemophilia A (PwHA). As part of its clinical development, a new instrument was required to measure treatment satisfaction. Aim Describe development of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae8ec6b6008bf3a76502045b4e42ba1
https://pubmed.ncbi.nlm.nih.gov/34131998
https://pubmed.ncbi.nlm.nih.gov/34131998
Publikováno v:
Forum for Health Economics and Policy. 19:71-86
Background: Since the start of the War on Cancer there have been enormous investments in improving oncology treatment. The return to society generated by this investment is unknown. We estimate the returns generated over the previous four decades and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::068b7287952676bb772ab53ce7d8344f
https://doi.org/10.1515/fhep-2014-0022
https://doi.org/10.1515/fhep-2014-0022
Autor:
Midori Shima, Anna Kiialainen, Nives Selak Bienz, Cédric Hermans, Christophe Schmitt, Sammy Chebon, Amy D. Shapiro, Gallia G. Levy, Nigel S. Key, Víctor Jiménez-Yuste, Agnès Portron, Steven W. Pipe, Kathelijne Peerlinck, Michaela Lehle, Maria Podolak-Dawidziak, Katsuyuki Fukutake, Avrita Campinha-Bacote
Publikováno v:
The Lancet. Haematology. 6(6)
Emicizumab, a subcutaneously administered, humanised, bispecific, monoclonal antibody, is approved to treat people with haemophilia A of all ages with and without coagulation factor VIII (FVIII) inhibitors. HAVEN 4 assessed emicizumab prophylaxis adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ab86d8bd221918498d0335ebf4a5a5
https://pubmed.ncbi.nlm.nih.gov/31003964
https://pubmed.ncbi.nlm.nih.gov/31003964
Preference for Emicizumab over Prior Factor Treatments: Results from the HAVEN 3 and HAVEN 4 Studies
Autor:
Sammy Chebon, Midori Shima, Adam Giermasz, Avrita Campinha-Bacote, Jerzy Windyga, Steven W. Pipe, Johannes Oldenburg, Peter Trask, Víctor Jiménez-Yuste, Ido Paz-Priel, Markus Niggli, Johnny Mahlangu, Aric Parnes, Michaela Lehle
Publikováno v:
Blood. 132:1187-1187
Background Hemophilia A with or without inhibitors to factor VIII (FVIII) has a major impact on the quality of life of people with this condition. This may be exacerbated by the treatment burden associated with current factor treatments that require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31a51673332e9c26fb62bf143e85008f
https://doi.org/10.1182/blood-2018-99-118132
https://doi.org/10.1182/blood-2018-99-118132
Autor:
Avrita Campinha-Bacote, Jue Wang, Heidi D. Klepin, Patrick Phuong, Peter Trask, Mehrdad Mobasher, Wan-Jen Hong
Publikováno v:
Blood. 132:4076-4076
Introduction The measurement, analysis, and communication of treatment-related symptoms and their impact on the functioning of individuals in clinical trials is an area of interest to the medical community, the Food and Drug Administration and other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9c71ad240f1b3c2500efa1cf3769ff0
https://doi.org/10.1182/blood-2018-99-116038
https://doi.org/10.1182/blood-2018-99-116038
Autor:
Avrita Campinha-Bacote, Patrick Phuong, Jue Wang, Heidi D. Klepin, Mehrdad Mobasher, Wan-Jen Hong, Peter Trask
Publikováno v:
Journal of Clinical Oncology. 36:e22040-e22040
e22040Background: Novel therapies are needed for older patients (pts) with acute myeloid leukemia (AML). Functional impairments and age-related comorbidities can limit treatment (tx) tolerance. Con...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::382e039c775ce460aee4ff672bbcad11
https://doi.org/10.1200/jco.2018.36.15_suppl.e22040
https://doi.org/10.1200/jco.2018.36.15_suppl.e22040